| APOA1 |
APOA1: Apolipoprotein A-I precursor |
C20orf185 |
C20orf185, LPLUNC3: Long palate, lung and nasal epithelium carcinoma-associated |
0.265 |
Evidence |
|
| IFNA17 |
IFNA17: Interferon alpha-17 precursor |
IL22RA2 |
IL22RA2, UNQ5793/PRO19598/PRO19822: Interleukin-22 receptor alpha-2 chain precur |
0.265 |
Evidence |
|
| IFNA21 |
IFNA21: Interferon alpha-21 precursor |
IL22RA2 |
IL22RA2, UNQ5793/PRO19598/PRO19822: Interleukin-22 receptor alpha-2 chain precur |
0.265 |
Evidence |
|
| IFNA10 |
IFNA10: Interferon alpha-10 precursor |
IL22RA2 |
IL22RA2, UNQ5793/PRO19598/PRO19822: Interleukin-22 receptor alpha-2 chain precur |
0.265 |
Evidence |
|
| TNF |
TNF, TNFA, TNFSF2: Tumor necrosis factor precursor |
TNFRSF18 |
TNFRSF18, AITR, UNQ319/PRO364, GITR: Tumor necrosis factor receptor superfamily |
0.265 |
Evidence |
|
| LTA |
LTA, TNFB, TNFSF1: Lymphotoxin-alpha precursor |
TNFRSF18 |
TNFRSF18, AITR, UNQ319/PRO364, GITR: Tumor necrosis factor receptor superfamily |
0.265 |
Evidence |
|
| CST4 |
CST4: Cystatin-S precursor |
TINAGL1 |
TINAGL1, GIS5, PP6614, LCN7, PSEC0088, OLRG2, UNQ204/PRO230, TINAGL: Tubulointer |
0.265 |
Evidence |
|
| CYB5R3 |
CYB5R3, DIA1: NADH-cytochrome b5 reductase 3 |
CYP8B1 |
CYP8B1, CYP12: Cytochrome P450 8B1 |
0.265 |
Evidence |
|
| CYB5R3 |
CYB5R3, DIA1: NADH-cytochrome b5 reductase 3 |
CYP2S1 |
IPI00396661 |
0.265 |
Evidence |
|
| CYB5R3 |
CYB5R3, DIA1: NADH-cytochrome b5 reductase 3 |
CYP26C1 |
CYP26C1: Cytochrome P450 26C1 |
0.265 |
Evidence |
|
| WNT11 |
WNT11: Protein Wnt-11 precursor |
SFRP5 |
SFRP5, FRP1B, SARP3: Secreted frizzled-related protein 5 precursor |
0.265 |
Evidence |
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
OLIG1 |
OLIG1: Oligodendrocyte transcription factor 1 |
0.265 |
Evidence |
|
| BCL10 |
BCL10, CIPER, CLAP: B-cell lymphoma/leukemia 10 |
TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
0.265 |
Evidence |
|
| BCL10 |
BCL10, CIPER, CLAP: B-cell lymphoma/leukemia 10 |
RNH1 |
RNH1, PRI, RNH: Ribonuclease inhibitor |
0.265 |
Evidence |
|
| TXNDC12 |
TXNDC12, TLP19, UNQ713/PRO1376: Thioredoxin domain-containing protein 12 precurs |
ERO1L |
ERO1L, UNQ434/PRO865: ERO1-like protein alpha precursor |
0.265 |
Evidence |
|
| TXNDC12 |
TXNDC12, TLP19, UNQ713/PRO1376: Thioredoxin domain-containing protein 12 precurs |
ERO1LB |
ERO1LB: ERO1-like protein beta precursor |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
OR1D4 |
Olfactory receptor OR17-2 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
UTS2R |
UTS2R, GPR14: Urotensin II receptor |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
OPN4 |
OPN4, MOP: Melanopsin |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GPR27 |
GPR27, SREB1: Probable G-protein coupled receptor 27 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GPR61 |
GPR61, BALGR: Probable G-protein coupled receptor 61 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GPR81 |
GPR81, GPR104, FKSG80: Probable G-protein coupled receptor 81 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
TAAR6 |
TAAR6, TA4, TAR4, TRAR4: Trace amine-associated receptor 6 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
GPR78 |
GPR78, UNQ5925/PRO19818: Probable G-protein coupled receptor 78 |
0.265 |
Evidence |
|
| GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
OXGR1 |
OXGR1, GPR80, GPR99, P2RY15, P2Y15: 2-oxoglutarate receptor 1 |
0.265 |
Evidence |
|